Most often, anti-phospholipid autoantibodies are detected after a clotting event or recurrent miscarriages. Therefore, the main goal of therapy is the prevention of recurrences, because the presence of the antibodies puts the patient at strong risk for future episodes. Vascular events –Acute thrombotic events are treated with anticoagulants (blood thinners). Subcutaneous injections are the standard therapy for preventing miscarriages. The therapy is started at the beginning of the pregnancy and continued in the period immediately after the delivery. This therapeutic approach has been shown to be effective in the majority of the cases, with the delivery of healthy babies. In non-responsive cases, additional therapies such as intravenous immunoglobulin infusions and administration of corticosteroids (prednisone) may help.
.
